The expression of FEZF1-AS1 is closely related to the TNM stages and overall survival of HCC, PC, CRC, BC, OS, NSCLC and GC, as well as the poor prognosis of various malignancies, including PC, CC, lung adenocarcinoma (LAD) and GC. Here, FEZF1 is linked to colorectal carcinoma.